SLC16A3 and rheumatoid arthritis: SLC16A3 is highly expressed by synovial fibroblasts (FLS) in RA synovial tissue, and silencing SLC16A3 inhibited the proliferation of RA-derived FLS and reduced disease severity in a RA mouse model [112].